Reference SummarySmith GS, J Natl Cancer Inst 1973 May;50(5):1195-213
Title |
Lifespan and incidence of cancer and other diseases in selected long-lived inbred mice and their F 1 hybrids. |
Authors |
Smith GS; Walford RL; Mickey MR |
Journal |
J Natl Cancer Inst |
Volume |
50 |
Issue |
5 |
Year |
1973 |
Pages |
1195-213 |
Abstract |
|
Links |
J:22620 – MGI References 4351393 – National Library of Medicine/PubMed |
Strain | Model Name | Treatment Agent(s) | Organ Affected | Frequency | Model Details |
---|---|---|---|---|---|
LP/J | Leukocyte lymphoma | Leukocyte |
1.3 - 7.8 |
||
129P3/J | Leukocyte lymphoma | Leukocyte |
2.4 - 7.4 |
||
(LP/J x 129P3/J)F1 | Leukocyte lymphoma | Leukocyte |
5.6 - 13 |
||
DBA/2J | Leukocyte lymphoma | Leukocyte |
10 - 12 |
||
(LP/J x DBA/2J)F1 | Leukocyte lymphoma | Leukocyte |
4.7 - 19 |
||
(129P3/J x DBA/2J)F1 | Leukocyte lymphoma | Leukocyte |
5.2 - 11 |
||
CBA/J | Leukocyte lymphoma | Leukocyte |
5.9 - 15 |
||
C57BL/10ScSn | Leukocyte lymphoma | Leukocyte |
29 - 31 |
||
(CBA/J x C57BL/10ScSn)F1 | Leukocyte lymphoma | Leukocyte |
5 - 14 |
||
(LP/J x C57BL/10ScSn)F1 | Leukocyte lymphoma | Leukocyte |
19 - 33 |
||
(A/J x C57BL/10ScSn)F1 | Leukocyte lymphoma | Leukocyte |
29 - 42 |
||
C3H.K | Leukocyte lymphoma | Leukocyte |
8 |
||
(CBA/J x C3H.K)F1 | Leukocyte lymphoma | Leukocyte |
9.5 |
||
C3H | Leukocyte lymphoma | Leukocyte |
17 |
||
(C3H x C3H.K)F1 | Leukocyte lymphoma | Leukocyte |
11 |
||
LP/J | Liver hepatoma | Liver |
2.0 - 6.5 |
||
129P3/J | Liver hepatoma | Liver |
0 - 2.1 |
||
(LP/J x 129P3/J)F1 | Liver hepatoma | Liver |
5.2 - 7.4 |
||
DBA/2J | Liver hepatoma | Liver |
0 - 1.5 |
||
(LP/J x DBA/2J)F1 | Liver hepatoma | Liver |
2.3 - 9.5 |
||
(129P3/J x DBA/2J)F1 | Liver hepatoma | Liver |
6.9 - 19 |
||
CBA/J | Liver hepatoma | Liver |
0 - 24 |
||
C57BL/10ScSn | Liver hepatoma | Liver |
0 - 2.6 |
||
(CBA/J x C57BL/10ScSn)F1 | Liver hepatoma | Liver |
3.4 - 7.5 |
||
(LP/J x C57BL/10ScSn)F1 | Liver hepatoma | Liver |
2.1 - 7.1 |
||
(A/J x C57BL/10ScSn)F1 | Liver hepatoma | Liver |
1.4 - 2.4 |
||
C3H.K | Liver hepatoma | Liver |
32 |
||
(CBA/J x C3H.K)F1 | Liver hepatoma | Liver |
43 |
||
C3H | Liver hepatoma | Liver |
14 |
||
(C3H x C3H.K)F1 | Liver hepatoma | Liver |
25 |
||
LP/J | Lung tumor | Lung |
3.9 - 5.2 |
||
129P3/J | Lung tumor | Lung |
0 - 1.1 |
||
(LP/J x 129P3/J)F1 | Lung tumor | Lung |
5.2 - 11 |
||
DBA/2J | Lung tumor | Lung |
0 |
||
(LP/J x DBA/2J)F1 | Lung tumor | Lung |
4.7 - 4.8 |
||
(129P3/J x DBA/2J)F1 | Lung tumor | Lung |
3.4 - 6.4 |
||
CBA/J | Lung tumor | Lung |
0 |
||
C57BL/10ScSn | Lung tumor | Lung |
0 - 2.9 |
||
(CBA/J x C57BL/10ScSn)F1 | Lung tumor | Lung |
0 - 2.5 |
||
(LP/J x C57BL/10ScSn)F1 | Lung tumor | Lung |
8.3 - 9.5 |
||
A/J | Lung tumor | Lung |
6 - 14 |
||
(A/J x C57BL/10ScSn)F1 | Lung tumor | Lung |
12 - 14 |
||
C3H.K | Lung tumor | Lung |
0 |
||
(CBA/J x C3H.K)F1 | Lung tumor | Lung |
0 |
||
C3H | Lung tumor | Lung |
6.9 |
||
(C3H x C3H.K)F1 | Lung tumor | Lung |
5.6 |
||
LP/J | Mammary gland tumor | Mammary gland |
2.6 - 14 |
||
129P3/J | Mammary gland tumor | Mammary gland |
0 |
||
(LP/J x 129P3/J)F1 | Mammary gland tumor | Mammary gland |
0 |
||
DBA/2J | Mammary gland tumor | Mammary gland |
0 - 31 |
||
(LP/J x DBA/2J)F1 | Mammary gland tumor | Mammary gland |
0 - 44 |
||
(129P3/J x DBA/2J)F1 | Mammary gland tumor | Mammary gland |
2.1 - 12 |
||
CBA/J | Mammary gland tumor | Mammary gland |
0 - 33 |
||
C57BL/10ScSn | Mammary gland tumor | Mammary gland |
0 |
||
(CBA/J x C57BL/10ScSn)F1 | Mammary gland tumor | Mammary gland |
0 - 21 |
||
(LP/J x C57BL/10ScSn)F1 | Mammary gland tumor | Mammary gland |
0 - 2.1 |
||
A/J | Mammary gland tumor | Mammary gland |
1 |
||
(A/J x C57BL/10ScSn)F1 | Mammary gland tumor | Mammary gland |
0 - 2.4 |
||
C3H.K | Mammary gland tumor | Mammary gland |
0 |
||
C3H | Mammary gland tumor | Mammary gland |
0 |
||
LP/J | Mesodermal cell/mesoblast sarcoma | Mesodermal cell/mesoblast |
5.9 - 6.5 |
||
129P3/J | Mesodermal cell/mesoblast sarcoma | Mesodermal cell/mesoblast |
1.1 - 2.4 |
||
(LP/J x 129P3/J)F1 | Mesodermal cell/mesoblast sarcoma | Mesodermal cell/mesoblast |
1.3 - 1.9 |
||
DBA/2J | Mesodermal cell/mesoblast sarcoma | Mesodermal cell/mesoblast |
0 - 3.0 |
||
(LP/J x DBA/2J)F1 | Mesodermal cell/mesoblast sarcoma | Mesodermal cell/mesoblast |
4.8 - 7.0 |
||
(129P3/J x DBA/2J)F1 | Mesodermal cell/mesoblast sarcoma | Mesodermal cell/mesoblast |
1.7 - 4.3 |
||
CBA/J | Mesodermal cell/mesoblast sarcoma | Mesodermal cell/mesoblast |
0 - 3.0 |
||
C57BL/10ScSn | Mesodermal cell/mesoblast sarcoma | Mesodermal cell/mesoblast |
0 |
||
(CBA/J x C57BL/10ScSn)F1 | Mesodermal cell/mesoblast sarcoma | Mesodermal cell/mesoblast |
0 - 3.4 |
||
(LP/J x C57BL/10ScSn)F1 | Mesodermal cell/mesoblast sarcoma | Mesodermal cell/mesoblast |
2.1 - 9.5 |
||
(A/J x C57BL/10ScSn)F1 | Mesodermal cell/mesoblast sarcoma | Mesodermal cell/mesoblast |
0 - 5.6 |
||
C3H.K | Mesodermal cell/mesoblast sarcoma | Mesodermal cell/mesoblast |
4 |
||
(CBA/J x C3H.K)F1 | Mesodermal cell/mesoblast sarcoma | Mesodermal cell/mesoblast |
0 |
||
C3H | Mesodermal cell/mesoblast sarcoma | Mesodermal cell/mesoblast |
0 |
||
(C3H x C3H.K)F1 | Mesodermal cell/mesoblast sarcoma | Mesodermal cell/mesoblast |
0 |
||
LP/J | Seminal vesicle tumor | Seminal vesicle |
1.3 |
||
LP/J | (Unspecified organ) adenocarcinoma | (Unspecified organ) |
2.0 |
||
129P3/J | (Unspecified organ) adenocarcinoma | (Unspecified organ) |
2.1 |
||
(LP/J x 129P3/J)F1 | (Unspecified organ) adenocarcinoma | (Unspecified organ) |
5.2 |
||
DBA/2J | (Unspecified organ) adenocarcinoma | (Unspecified organ) |
3.9 |
||
(129P3/J x DBA/2J)F1 | (Unspecified organ) adenocarcinoma | (Unspecified organ) |
3.4 |
||
CBA/J | (Unspecified organ) adenocarcinoma | (Unspecified organ) |
3.0 |
||
LP/J | (Unspecified organ) tumor | (Unspecified organ) |
0 - 1.3 |
||
129P3/J | (Unspecified organ) tumor | (Unspecified organ) |
0 - 1.1 |
||
(LP/J x 129P3/J)F1 | (Unspecified organ) tumor | (Unspecified organ) |
0 - 2.6 |
||
DBA/2J | (Unspecified organ) tumor | (Unspecified organ) |
0 - 2.0 |
||
(LP/J x DBA/2J)F1 | (Unspecified organ) tumor | (Unspecified organ) |
0 - 4.7 |
||
(129P3/J x DBA/2J)F1 | (Unspecified organ) tumor | (Unspecified organ) |
0 - 4.3 |
||
CBA/J | (Unspecified organ) tumor | (Unspecified organ) |
0 |
||
C57BL/10ScSn | (Unspecified organ) tumor | (Unspecified organ) |
0 - 2.9 |
||
(CBA/J x C57BL/10ScSn)F1 | (Unspecified organ) tumor | (Unspecified organ) |
0 |
||
(LP/J x C57BL/10ScSn)F1 | (Unspecified organ) tumor | (Unspecified organ) |
0 - 2.1 |
||
C3H.K | (Unspecified organ) tumor | (Unspecified organ) |
0 |
||
C3H | (Unspecified organ) tumor | (Unspecified organ) |
0 |
||
LP/J | (Unspecified organ) tumor - benign | (Unspecified organ) |
0 - 3.9 |
||
129P3/J | (Unspecified organ) tumor - benign | (Unspecified organ) |
2.4 - 3.2 |
||
(LP/J x 129P3/J)F1 | (Unspecified organ) tumor - benign | (Unspecified organ) |
0 - 1.9 |
||
DBA/2J | (Unspecified organ) tumor - benign | (Unspecified organ) |
0 - 1.5 |
||
(LP/J x DBA/2J)F1 | (Unspecified organ) tumor - benign | (Unspecified organ) |
0 |
||
(129P3/J x DBA/2J)F1 | (Unspecified organ) tumor - benign | (Unspecified organ) |
0 - 3.4 |
||
CBA/J | (Unspecified organ) tumor - benign | (Unspecified organ) |
0 |
||
C57BL/10ScSn | (Unspecified organ) tumor - benign | (Unspecified organ) |
0 |
||
(CBA/J x C57BL/10ScSn)F1 | (Unspecified organ) tumor - benign | (Unspecified organ) |
0 - 3.4 |
||
(LP/J x C57BL/10ScSn)F1 | (Unspecified organ) tumor - benign | (Unspecified organ) |
0 |
||
C3H.K | (Unspecified organ) tumor - benign | (Unspecified organ) |
0 |
||
C3H | (Unspecified organ) tumor - benign | (Unspecified organ) |
0 |